ATF3 Within the Interferon Signaling Pathway: A Potential Biomarker for Predicting Pathological Response to Neoadjuvant Chemoimmunotherapy

ABSTRACT Background Neoadjuvant chemoimmunotherapy has achieved high downstaging and pathologic response rates in nonsmall‐cell lung cancer (NSCLC), but outcomes vary significantly. Early identification of beneficiaries remains a challenge. Methods This study analyzed baseline transcriptomic data fr...

詳細記述

書誌詳細

出版年:	Thoracic Cancer
主要な著者:	Chao He, Rui Han, Taiming Zhang, Peng Zhong, Daijuan Huang, Conghua Lu, Yimin Zhang, Jianghua Li, Yuwen Deng, Yong He
フォーマット:	論文
言語:	英語
出版事項:	Wiley 2025-04-01
主題:	ATF3 biomarkers chemoimmunotherapy IFN signaling pathway NSCLC pathological response
オンライン･アクセス:	https://doi.org/10.1111/1759-7714.70056